CodeBlue
  • About Us
  • Malaysia
  • World
  • Opinions
  • Contact Us

Tag: dacomitinib

post-image
28 November 2019
World

Study: Asian Advanced Lung Cancer Patients Survive Three Years With New Treatment

Median overall survival on targeted therapy dacomitinib was 37.7 months, compared to 29.1 months for gefitinib.

Trending

post-image
Malaysia Jun 22, 2022

Ipoh Teacher Dies In Ambulance Response That Allegedly Skipped CPR

post-image
Malaysia Jun 24, 2022

Kula: Ipoh Residents Worried, HRPB Must Suspend Paramedic Pending Probe

post-image
Malaysia Jun 24, 2022

Sunway Healthcare Group Joins Forces With UKM To Expand Medical Related Resources In Malaysia

post-image
Malaysia Jun 24, 2022

HRPB Defends Paramedic, Patient Pronounced Dead In 10-Minute Response Time

post-image
Letter Jun 27, 2022

The Three Covid-19 Pandemics – Dr Amar-Singh HSS

img
Copyright @2022 CodeBlue | Social Health Analytics Sdn Bhd (1239011-M)